The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

REFER A COLLEAGUE: MarcinkoAdvisors@msn.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

Your Referral Count -0-

How dermatology became the hottest field in medicine.

CITE: https://www.r2library.com/Resource

STOCKS UP

• Talk about cutting it close: Super Micro Computer filed a much-delayed financial plan at the 11th hour, avoiding a delisting from the Nasdaq. Shares soared 31.24%.
• AI-enabled robotics company Symbotic surged 27.68% after announcing an impressive beat-and-raise quarter.
• MicroStrategy climbed another 11.89% after yesterday’s huge surge. The crypto company announced it will continue to purchase more bitcoin in the weeks ahead.

STOCKS DOWN

• More Trump Trade 2.0 developments: The newly formed Department of Government Efficiency is considering creating an app that allows Americans to file their taxes on a phone for free. Intuit sank 5.10%, and H&R Block dropped 8.31% on the news.
• Speaking of Trump, platform Bakkt popped then dropped 0.67% following yesterday’s news that Trump Media & Technology Group may acquire the company. Trump Media shares fell 8.88%.
• Kraft Heinz fell 1.58% on a Piper Sandler downgrade due to the company’s slow retail sales and the threat of new government regulations from the Health Department.
• Lowe’s may have beaten top and bottom line expectations last quarter, but the home improvement retailer’s forecast of slower sales next year sent the stock falling 4.62%.
• Incyte tumbled 8.33% after the pharma company announced it was pausing the Phase 2 trial of its new spontaneous hives treatment.

CITE: https://tinyurl.com/2h47urt5

Here’s where the major benchmarks ended:

•  The S&P 500^® index (SPX) was up 23.36 points (0.4%) to 5916.98; the Dow Jones Industrial Average^® ($DJI) dipped 120.66 points (0.28%) to 43,268.94; and the NASDAQ Composite^® ($COMP) rose 195.66 points (1.04%) to 18,987.49.
• The 10-year Treasury note yield fell four basis points to 4.38%.
• The CBOE Volatility Index^® (VIX) eased to 16.04 after an earlier pop above 17.

CITE: https://tinyurl.com/tj8smmes

Oura rings will soon be integrated with glucose biosensors after a $75 million series D funding round with medical device maker Dexcom.

Visualize: How private equity tangled banks in a web of debt, from the Financial Times.

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Filed under: Drugs and Pharma, Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors | Tagged: biosensors, business, CBOE, dermatology, Dexcom, DJIA, DOW, finance, glucose, Marcinko, NASA, NASDAQ, Oura rings, S&P 500, stock markets, stocks, textbooks, TNX, VIX, WSJ | Leave a comment »